ArticleCell reports. Medicine2024

IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy.

Kun-Joo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.